John Germak

1.3k total citations
37 papers, 980 citations indexed

About

John Germak is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Genetics. According to data from OpenAlex, John Germak has authored 37 papers receiving a total of 980 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Endocrinology, Diabetes and Metabolism, 12 papers in Molecular Biology and 10 papers in Genetics. Recurrent topics in John Germak's work include Growth Hormone and Insulin-like Growth Factors (15 papers), Sexual Differentiation and Disorders (8 papers) and Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (6 papers). John Germak is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (15 papers), Sexual Differentiation and Disorders (8 papers) and Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (6 papers). John Germak collaborates with scholars based in United States, Denmark and Germany. John Germak's co-authors include Robert Gut, Judith L. Ross, Peter A. Lee, Alan D. Rogol, Diane F. Matesic, Wayne Weng, Pinchas Cohen, Anne‐Marie Kappelgaard, Ron G. Rosenfeld and Clifford R. Pohl and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Endocrinology and The Journal of Pediatrics.

In The Last Decade

John Germak

37 papers receiving 941 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Germak United States 21 491 339 339 218 121 37 980
Giorgio Radetti Italy 18 634 1.3× 347 1.0× 249 0.7× 319 1.5× 190 1.6× 57 1.2k
Giovanna Municchi Italy 17 598 1.2× 511 1.5× 184 0.5× 416 1.9× 128 1.1× 32 1.1k
Sara Pagani Italy 20 350 0.7× 180 0.5× 167 0.5× 240 1.1× 49 0.4× 69 1.1k
Salvatore Seminara Italy 17 270 0.5× 342 1.0× 116 0.3× 280 1.3× 133 1.1× 54 1.0k
P. Borrelli Italy 17 498 1.0× 330 1.0× 159 0.5× 310 1.4× 60 0.5× 40 1.0k
O Butenandt Germany 19 596 1.2× 391 1.2× 272 0.8× 258 1.2× 78 0.6× 77 1.1k
Dick Mul Netherlands 19 550 1.1× 324 1.0× 210 0.6× 298 1.4× 153 1.3× 63 1.2k
Delphine Zénaty France 18 306 0.6× 438 1.3× 168 0.5× 522 2.4× 92 0.8× 34 1000
Makoto Anzo Japan 18 296 0.6× 259 0.8× 133 0.4× 147 0.7× 118 1.0× 35 794
B.J. Otten Netherlands 26 713 1.5× 987 2.9× 288 0.8× 594 2.7× 102 0.8× 55 1.7k

Countries citing papers authored by John Germak

Since Specialization
Citations

This map shows the geographic impact of John Germak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Germak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Germak more than expected).

Fields of papers citing papers by John Germak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Germak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Germak. The network helps show where John Germak may publish in the future.

Co-authorship network of co-authors of John Germak

This figure shows the co-authorship network connecting the top 25 collaborators of John Germak. A scholar is included among the top collaborators of John Germak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Germak. John Germak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ross, Judith L., Peter A. Lee, Robert Gut, & John Germak. (2015). Attaining genetic height potential: Analysis of height outcomes from the ANSWER Program in children treated with growth hormone over 5 years. Growth Hormone & IGF Research. 25(6). 286–293. 31 indexed citations
3.
Lee, Peter A., Judith L. Ross, Bente Klarlund Pedersen, et al.. (2015). Noonan syndrome and Turner syndrome patients respond similarly to 4 years’ growth-hormone therapy: longitudinal analysis of growth-hormone-naïve patients enrolled in the NordiNet® International Outcome Study and the ANSWER Program. International Journal of Pediatric Endocrinology. 2015(1). 17–17. 20 indexed citations
4.
5.
Rose, Susan R., G. D. Reeves, Robert Gut, & John Germak. (2015). Attention-Deficit/Hyperactivity Disorder Medication Treatment Impact on Response to Growth Hormone Therapy: Results from the ANSWER Program, a Non-Interventional Study. The Journal of Pediatrics. 167(6). 1389–1396. 8 indexed citations
6.
Miller, Bradley S., Deborah Rotenstein, Larry C. Deeb, John Germak, & Tami Wisniewski. (2014). Persistence with growth hormone therapy in pediatric patients. The American Journal of Managed Care. 6(1). 5 indexed citations
7.
Botteman, Marc, et al.. (2012). PDB29 Budget Impact Analysis of Norditropin Versus Three Leading Market Growth Hormone Therapies. Value in Health. 15(4). A175–A175. 1 indexed citations
8.
Lee, Peter A., John Germak, Robert Gut, Naum Khutoryansky, & Judith L. Ross. (2011). Identification of factors associated with good response to growth hormone therapy in children with short stature: results from the ANSWER Program®. International Journal of Pediatric Endocrinology. 2011(1). 6–6. 35 indexed citations
9.
Ross, Judith L., Peter A. Lee, Robert Gut, & John Germak. (2011). Impact of Age and Duration of Growth Hormone Therapy in Children with Turner Syndrome. Hormone Research in Paediatrics. 76(6). 392–399. 23 indexed citations
10.
Ross, Judith L., Peter A. Lee, Robert Gut, & John Germak. (2010). Factors Influencing the One- and Two-Year Growth Response in Children Treated with Growth Hormone: Analysis from an Observational Study. International Journal of Pediatric Endocrinology. 2010. 1–7. 36 indexed citations
11.
Kalpatthi, Ram, et al.. (2006). Thyroid abnormalities in infantile hepatic hemangioendothelioma. Pediatric Blood & Cancer. 49(7). 1021–1024. 26 indexed citations
12.
Parker, Elizabeth, Karine Hovanes, John Germak, Forbes D. Porter, & Deborah P. Merke. (2006). Maternal 21‐hydroxylase deficiency and uniparental isodisomy of chromosome 6 and X results in a child with 21‐hydroxylase deficiency and Klinefelter syndrome. American Journal of Medical Genetics Part A. 140A(20). 2236–2240. 36 indexed citations
13.
Benavides, Sandra, et al.. (2005). Efficacy and Safety of Hypoglycemic Drugs in Children with Type 2 Diabetes Mellitus. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 25(6). 803–809. 11 indexed citations
14.
Biebermann, Heike, Torsten Schöneberg, Claudia Hess, et al.. (2001). The First Activating TSH Receptor Mutation in Transmembrane Domain 1 Identified in a Family with Nonautoimmune Hyperthyroidism. The Journal of Clinical Endocrinology & Metabolism. 86(9). 4429–4433. 43 indexed citations
15.
Felner, Eric I., John Marks, & John Germak. (2001). A Variation of Vitamin D Deficiency in Children. Journal of Pediatric Endocrinology and Metabolism. 14(2). 203–6. 4 indexed citations
16.
Oeffinger, Kevin C., George R. Buchanan, Debra A. Eshelman, et al.. (2001). Cardiovascular Risk Factors in Young Adult Survivors of Childhood Acute Lymphoblastic Leukemia. ˜The œAmerican journal of pediatric hematology/oncology. 23(7). 424–430. 150 indexed citations
17.
Matesic, Diane F., Barbara Attardi, Tammy Dellovade, Donald W. Pfaff, & John Germak. (1997). Differential LHRH Secretion, Dye Coupling, and Protein Expression in Two Morphologically Distinct Cell Types Identified in GT1–7 Cultures. Journal of Neuroendocrinology. 9(6). 467–478. 13 indexed citations
18.
Germak, John. (1996). Growth hormone therapy in children with short stature: Is bigger better or achievable?. The Indian Journal of Pediatrics. 63(5). 591–597. 2 indexed citations
19.
20.
Germak, John, et al.. (1990). Longitudinal assessment of l-thyroxine therapy for congenital hypothyroidism. The Journal of Pediatrics. 117(2). 211–219. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giorgio Radetti Breakdown of academic impact, for papers by Giovanna Municchi Breakdown of academic impact, for papers by Sara Pagani Breakdown of academic impact, for papers by Salvatore Seminara Breakdown of academic impact, for papers by P. Borrelli Breakdown of academic impact, for papers by O Butenandt Breakdown of academic impact, for papers by Dick Mul Breakdown of academic impact, for papers by Delphine Zénaty Breakdown of academic impact, for papers by Makoto Anzo Breakdown of academic impact, for papers by B.J. Otten
Rankless by CCL
2026